---
title: "OpenAI's CEO Altman: The company may seek partners or invest in AI drug discovery"
description: "OpenAI's CEO Altman: The company may seek partners or invest in AI drug discovery"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274693328.md"
published_at: "2026-02-03T17:45:14.000Z"
---

# OpenAI's CEO Altman: The company may seek partners or invest in AI drug discovery

OpenAI's CEO Altman: The company may seek partners or invest in AI drug discovery

### Related Stocks

- [520500.CN - Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)](https://longbridge.com/en/quote/520500.CN.md)
- [159992.CN - Yinhua CSI Innovative Drugs Industry ETF](https://longbridge.com/en/quote/159992.CN.md)
- [RLAY.US - Relay Therapeutics](https://longbridge.com/en/quote/RLAY.US.md)
- [159883.CN - Maxwealth CSI All Share Medical Apparatus and Instruments ETF](https://longbridge.com/en/quote/159883.CN.md)
- [SBIO.US - ALPS Medical Breakthrough](https://longbridge.com/en/quote/SBIO.US.md)
- [510660.CN - ChinaAMC SSE Health Care ETF Initiating Fund](https://longbridge.com/en/quote/510660.CN.md)
- [513060.CN - Bosera Hang Seng Health Care ETF(QDII)](https://longbridge.com/en/quote/513060.CN.md)
- [159570.CN - China Universal CNI HK Connect Innovative Drugs Industry ETF](https://longbridge.com/en/quote/159570.CN.md)
- [562050.CN - Hwabao WP CSI Pharmaceuticals ETF](https://longbridge.com/en/quote/562050.CN.md)
- [159837.CN - E Fund CSI Biotechnology Theme ETF](https://longbridge.com/en/quote/159837.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 期權市場向我們揭示了關於 Moderna 的哪些信息 | 鯨魚們對 Moderna（納斯達克代碼：MRNA）持樂觀態度，最近 45% 的期權交易反映出看漲預期。交易的總量包括價值 774,679 美元的 4 個看跌期權和總計 1,215,014 美元的 18 個看漲期權。價格目標範圍從 30 美元 | [Link](https://longbridge.com/en/news/276780530.md) |
| Bowtie 新總部進駐灣仔 去年下半年自願醫保投保量逾 1 萬 | 香港虛擬保險公司保泰人壽（Bowtie）在灣仔新總部「保泰人壽大廈」揭幕，籤訂 5 年租約，承租 7 層樓面。去年下半年自願醫保投保量達 1 萬張，按年倍增，反映市民投保習慣轉變。公司強調實體據點可增強客戶信心，個人客戶佔比超過 50%。財 | [Link](https://longbridge.com/en/news/276862835.md) |
| ETMESCIUS USA, Inc. 發佈了 ActiveReports.NET v20 | MESCIUS USA Inc. 宣佈發佈 ActiveReports.NET v20，針對開發人員創建動態報告的效率進行了增強。主要功能包括智能數據區域，以快速生成報告，以及 AI 圖像到報告功能，將靜態圖像轉換為可編輯佈局。更新後的基於 | [Link](https://longbridge.com/en/news/277037715.md) |
| Recursion Pharmaceuticals｜10-K：2025 財年營收 74.68 百萬美元超過預期 |  | [Link](https://longbridge.com/en/news/276879117.md) |
| ETDataJoint 推出 Agentic AI 控制層以支持科學工作流程，從而在受監管的研發中實現可辯護和可重複的 AI | DataJoint 推出了 DataJoint Agentic AI，這是一個用於科學工作流的受管執行層，增強了在受監管的研發環境中 AI 的可靠性。該平台捕獲多模態科學數據及豐富的元數據，確保 AI 驅動的洞察具有可重複性和問責性。它支持 | [Link](https://longbridge.com/en/news/276936216.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.